Investors shouldn't replicate the concentration of Berkshire, but the following stocks could have a place in your portfolio.

The conglomerate beat analysts' operating profit target, but there were no share buybacks over the third quarter.

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Berkshire Hathaway (BRK-B, BRK-A) reported earnings over the weekend, with the company's cash pile reaching a record high of over $381 billion. Kimberly-Clark (KMB) will purchase Tylonel maker, Kenvue ...

Berkshire Hathaway's record cash reserves stem from soaring insurance income and stock sales in Q3, signalling a potential ...

Fed policy and funding markets may be a headwind, says Michael Wilson The stock market has worked out that corporate earnings are accelerating quicker than the average analyst. Many investors know ...

Supreme Court arguments over tariffs are coming, shutdown milestone approaches, China’s EV sales are slowing, and more news ...

The Fed is about to start boosting financial markets again. Here’s why. Is Big Tech’s soaring AI spending creating a bubble? Here’s what it means for stocks.

Investors will eye earnings, PMIs and a private-sector jobs gauge this week. Follow along for live news and analysis of the Dow, S&P 500 and Nasdaq.

Investors have long followed Buffett and team's stock picks via a massive portfolio within Berkshire Hathaway. Today, that ...

Investors will eye earnings, PMIs and a private-sector jobs gauge this week. Follow along for live news and analysis of the Dow, S&P 500 and Nasdaq.